Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Jnj
Recent news which mentions Jnj
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
September 30, 2024
Tickers
JNJ
LEGN
NEWS
Tags
JNJ
Stories That Matter
Expert Ideas
From
Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Tickers
ABT
JNJ
Tags
Recent Press Releases
Market News
ABT
From
Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
September 27, 2024
Tickers
JNJ
NEWS
Tags
Top Stories
Market News
Stories That Matter
From
Benzinga
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
September 26, 2024
Tickers
JNJ
NEWS
Tags
News
Markets
Market News
From
Benzinga
Why Masimo Stock Crushed the Market Today
September 25, 2024
Tickers
JNJ
KFY
MASI
Tags
JNJ
MASI
Market News
From
Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
Large Cap
Rumors
Biotech
From
Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
Tickers
ABT
JNJ
Tags
ABT
JNJ
Market News
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
VKTX
JNJ
CI
From
Benzinga
Is Johnson & Johnson Stock a Buy?
September 21, 2024
Tickers
JNJ
Tags
JNJ
Market News
Recent Press Releases
From
Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Tickers
JNJ
NEWS
Tags
Biotech
Large Cap
Equities
From
Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Tickers
JNJ
NEWS
ZVRA
Tags
Biotech
News
Briefs
From
Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Tickers
JNJ
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
September 19, 2024
Tickers
AAPL
AMZN
AVGO
GOOG
Tags
VYM
JPM
Recent Press Releases
From
Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
Tickers
AZN
BGNE
JNJ
NEWS
Tags
General
News
Briefs
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
SNY
MRNA
Recent Press Releases
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
Options
Benzinga
JNJ
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
Benzinga
Trading Ideas
Markets
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
Benzinga
Trading Ideas
Market News
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
Media
Market News
FDA
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Stories That Matter
JNJ
Top Stories
From
Benzinga
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
September 11, 2024
Tickers
JNJ
NEWS
Tags
Top Stories
Market News
Stories That Matter
From
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Tickers
HIMS
JNJ
LLY
MRNA
Tags
TDOC
Recent Press Releases
TGT
From
Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
Tickers
ABT
JNJ
Tags
ABT
JNJ
Market News
From
Motley Fool
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
Tickers
JNJ
NEWS
PTGX
TAK
Tags
Market News
Analyst Ratings
TAK
From
Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
Tickers
JNJ
KVUE
Tags
Golden Cross
Technicals
Top Stories
From
Benzinga
Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
September 06, 2024
Tickers
AAPL
CSGP
DELL
JNJ
Tags
Joshua Brown
News
Bill Baruch
From
Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 06, 2024
Tickers
CVS
JNJ
NEWS
PDCO
Tags
Expert Ideas
Markets
JNJ
From
Benzinga
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
September 05, 2024
Tickers
JNJ
NEWS
Tags
Benzinga
Media
Market News
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
JNJ
COMP
Biopharma
From
Benzinga
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
September 05, 2024
Tickers
INTC
JNJ
MO
WBA
Tags
Recent Press Releases
WBA
MO
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.